|
Volumn 86, Issue 10, 2000, Pages 1073-1079
|
The PARAGON stent study: A randomized trial of a new martensitic nitinol stent versus the Palmaz-Schatz stent for treatment of complex native coronary arterial lesions
a b c a d e f c |
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
HEPARIN;
NITINOL;
STAINLESS STEEL;
TICLOPIDINE;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ANGIOGRAPHY;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CORONARY STENT;
DEVICE;
DIABETES MELLITUS;
FEMALE;
HEART MUSCLE ISCHEMIA;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESTENOSIS;
REVASCULARIZATION;
RISK FACTOR;
STATISTICAL ANALYSIS;
THROMBOSIS;
TREATMENT OUTCOME;
UNSTABLE ANGINA PECTORIS;
ADULT;
AGED;
AGED, 80 AND OVER;
ALLOYS;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
CORONARY ANGIOGRAPHY;
CORONARY DISEASE;
ELASTICITY;
EQUIPMENT DESIGN;
EQUIPMENT FAILURE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
RECURRENCE;
STAINLESS STEEL;
STENTS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 0034670112
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(00)01162-0 Document Type: Article |
Times cited : (19)
|
References (9)
|